BEXIMCO PHARMS USA
GenericsBEXIMCO PHARMS USA is a generic drug manufacturer focused on Dermatology, Infectious Disease.
BEXIMCO PHARMS USA's Key Drugs
BEXIMCO PHARMS USA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
BEXIMCO PHARMS USA's Recent FDA Approvals
New NDA/BLA approvals for BEXIMCO PHARMS USA over the last two years — novel drugs only, excluding generics and label supplements.
BEXIMCO PHARMS USA's Therapeutic Areas
BEXIMCO PHARMS USA's approved drugs and pipeline span 2 therapeutic areas, led by Dermatology and Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
BEXIMCO PHARMS USA's Top Competitors
BEXIMCO PHARMS USA's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and B BRAUN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
BEXIMCO PHARMS USA Pipeline Snapshot
Active clinical trials for BEXIMCO PHARMS USA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1991-06-28
- Latest
- 2014-08-12
- Applications
- 2